Current position:Home >Product >
N-[(5-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}pyridin-2-yl)carbonyl]glutamic acid
N-[(5-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}pyridin-2-yl)carbonyl]glutamic acid(29769-52-6)
- Name: N-[(5-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}pyridin-2-yl)carbonyl]glutamic acid
- Synonyms:Glutamicacid, N-[5-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]picolinoyl]-,L- (8CI); 2'-Azafolic acid; NSC 128299
- Molecular Formula:C18H18 N8 O6
- Molecular Weight:442.391
- CAS Registry Number:29769-52-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.29769-52-6 L-Glutamic acid,N-[[5-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-2-pyridinyl]carbonyl]-(9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
Other Product
- 35290-13-2/5-Hydroxy-4-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2-oxo-2H-1-benzopyran-6-carbaldehyde
- 101386-86-1/1,3-Benzenediol,5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]-
- 32058-56-3/3-Piperidinopropyl 2,2,4,4-tetramethylvalerate hydrochloride
- 39007-95-9/2,5-Cyclohexadien-1-one,2-acetyl-3,5-dihydroxy-4,4-dimethyl-6-[[2,4,6-trihydroxy-3-(1-oxobutyl)phenyl]methyl]-
- 18545-02-3/triisobutoxyvinylsilane
- 20482-31-9/1H-Benzocycloheptene,decahydro-2,2,5,9-tetramethyl- (9CI)
- 23758-20-5/(6aS)-7,7aβ,10,10aα,10bβ,10cβ-Hexahydro-6aβ-methyl-10-methylene-2H-difuro[4,3,2-ef:3',2'-h][3]benzoxepine-2,9(6aH)-dione
- 339308-60-0/Briakinumab
- 155468-58-9/3-Cyclohexene-1-carboxylicacid, 4-(4-methyl-3-penten-1-yl)-, 4-(5-decyl-2-pyrimidinyl)phenyl ester
- 18229-09-9/N,N-bis(2-chloroethyl)-P-morpholin-4-ylphosphonamidic acid - cyclohexanamine (1:1)
- 89229-91-4/gamma-methyl-1H-indole-3-propanol
- 36723-45-2/Bicyclo[4.1.0]hept-2-ene-3-methanol,7-methyl-7-(4-methyl-3-penten-1-yl)-, (1R,6S,7S)-
- 89011-86-9/1-Propanone, 3-(4-(2-(4-fluorophenyl)-2-(4-morpholinyl)ethyl)-1-piperazinyl)-2-methyl-1-phenyl-, (Z)-2-butenedioate (1:2)
- 7495-55-8/1-(6-methoxynaphthalen-2-yl)-5-methyloct-7-ene-1,4-dione
- 94465-73-3/Equisetum debile, ext.
- 4242-33-5/Diphenylacetic acid 2-fluoroethyl ester
- 184904-12-9/4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one,2,3-dihydro-2,5-dihydroxy-8,8-dimethyl-6-(3-methyl-2-butenyl)- (9CI)
- 6079-28-3/[1,1'-Biphenyl]-4-carboxamide,N-(9,10-dihydro-4-methyl-9,10-dioxo-1-anthracenyl)-
- 94107-41-2/N-(2-bromo-3-methylbutyryl)-3-phenyl-DL-alanine
- 29769-52-6/N-[(5-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}pyridin-2-yl)carbonyl]glutamic acid
- 90247-45-3/tetrasodium alpha,.alpha'.-(ethylenediimino)bis[(2-hydroxy-5-sulphonatophenyl)acetate]
- 85234-71-5/1H-Imidazole-4-carboxamide,5-amino-1-[(1R)-1-[(1S)-1-hydroxyethyl]heptyl]-, rel-
- 158027-98-6/mitochondrial import stimulation factor
- 153548-82-4/b-D-Glucopyranoside,[cis-4-(1-methylethenyl)cyclohexyl]methyl (9CI)
- 19519-78-9/1-Nitropropanal oxime
- 188861-11-2/Ergosta-2,5,24-trien-26-oicacid, 8,11,16,22-tetrahydroxy-1-oxo-, d-lactone, (11b,16b,22R)- (9CI)
- 64028-43-9/1,4-bis(chloromethyl)piperazine-2,5-dione
- 94713-21-0/Toluene-o-sulphonic acid, compound with N-(p-amino-o-hydroxyphenyl)-N-(p-cyanophenyl)urea (1:1)
- 147197-81-7/7-fluoro-2-phenyl-4-quinolone
- 6167-12-0/3-[5-({1-[4-(methoxycarbonyl)phenyl]-3,5-dioxopyrazolidin-4-ylidene}methyl)furan-2-yl]benzoic acid